Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Mr Greene has also worked on many complex M&A deals, including pharmaceutical company Mylan’s pending $50bn combination with Upjohn, a division of Pfizer....
...— And a primer on Mayweather v McGregor (Jack Slack) — China has a struggling industrial heartland of its own (Michael Schuman): There are too many unproductive, debt-laden factories that are losing...
...Then we speak with the FT’s David Crow about the potential consequences if a merger between Pfizer and Allergan every becomes reality, plus he catches us up on the Valeant saga....
...Their bigger worry is that the US drugs group could bungle the bid, as Pfizer did in pursuing AstraZeneca....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...Some support for equity markets came from a broadly encouraging batch of corporate earnings from the likes of Pfizer in the US and EDF in Europe....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...It signals the biggest takeover in the pharmaceutical sector since 2009, when Sanofi-Aventis and several of its larger peers were left behind by the large-scale takeovers of Wyeth by Pfizer, Schering-Plough...
...“It really comes down to a reputation and trust issue,” said Paul Duffy, vice-president for manufacturing in Ireland and Singapore at Pfizer, the American pharmaceuticals group....
...Cohen subsequently made phone calls from an outdoor pay phone to tip his uncle David V....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...Since first appearing in 1999, Vioxx and other cox-2 drugs such as Pfizer’s Celebrex and Bextra had been billed as super aspirins - better and safer than older painkillers....
...This scenario may well favour the chances of a candidate such as Mr Garcia or Mr Danino. Meanwhile, Mr Insulza was expected to meet US President George W Bush on Monday....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition